stockrow
Friday 6 November 2026
Export AMWL’s income statement to Excel — free account
American Well Corporation
AMWL Healthcare Health Information Services
American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024.
- Revenue
- −13.0%
- EPS
- +67.9%
- Free cash flow
- +22.0%
Quarter to September 2026, against a year earlier
11.94
0.17
−1.40%
Follow AMWL
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 5 | 4 |
| (33.93%) | (32.20%) | (29.54%) | (23.18%) | ||
| (25.19%) | (23.58%) | (21.82%) | (17.08%) | ||
ROIC |
(100.51%) | (95.94%) | (135.53%) | (91.47%) | |
Return on Tangible Assets |
(55.10%) | (50.09%) | (45.00%) | (34.24%) | |
Average Days of Receivables |
72.75 | 87.79 | 87.87 | 94.15 | |
Free Cash Flow per Share |
(4.11) | (2.69) | (1.91) | (1.64) | |
Free Cash Flow |
(65.97) | (44.63) | (32.04) | (27.92) | |
Capital Expenditures |
(0.02) | (2.80) | (5.65) | (8.63) | |
| Other line items | |||||
Cash ROIC |
(15.34%) | (10.62%) | (7.43%) | (6.86%) | |
Accounts Receivable Turnover |
4.10 | 3.68 | 4.12 | 3.84 | |
Accounts Payable Turnover |
34.95 | 28.59 | 38.77 | 20.68 | |
Inventory Turnover |
57.59 | 60.80 | 66.81 | 74.78 | |
Average Days of Payables |
5.17 | 4.53 | 5.89 | 13.84 | |
Days of Inventory on Hand |
3.72 | 3.75 | 3.35 | 3.20 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
29.22% | 26.60% | 25.28% | 21.90% | |
Selling, General and Administrative Expense of Revenue |
52.67% | 50.97% | 48.99% | 46.88% | |
Share Based Compensation of Revenue |
8.83% | 7.15% | 5.95% | 5.33% | |
Operating CF/Net income |
0.69 | 0.48 | 0.34 | 0.34 | |
Depreciation/Fixed assets |
167.12 | 209.24 | 217.48 | 209.63 | |
Capex/Depreciation |
0.00 | (0.08) | (0.16) | (0.27) | |
Revenue per Share |
15.54 | 14.31 | 13.04 | 12.38 | |
Operating CF per Share |
(4.11) | (2.52) | (1.57) | (1.13) | |
Capex per Share |
0.00 | (0.17) | (0.34) | (0.51) | |
Capex to Sales |
0.00 | 0.01 | 0.03 | 0.04 |
Columns are period end dates · fundamentals updated 5 Nov 2026